What is Xenon Pharmaceuticals's AOCI?

Xenon Pharmaceuticals (XENE) reported AOCI of -$1.21M in Q1 2026.

How has Xenon Pharmaceuticals's AOCI changed year-over-year?

Xenon Pharmaceuticals's AOCI decreased by 44.9% year-over-year, from -$836K to -$1.21M.

What is the long-term trend for Xenon Pharmaceuticals's AOCI?

Over 5 years (2020 to 2025), Xenon Pharmaceuticals's AOCI has grown at a -19.5% compound annual growth rate (CAGR), from -$990K to $335K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Xenon Pharmaceuticals XENE AOCI

AOCI at other companies

Eli LillyLLY

-$2.83B+24.9%

Johnson & JohnsonJNJ

-$14.83B-26.3%

Jazz PharmaceuticalsJAZZ

-$651M+17.1%

Praxis Precision Medicines, Inc.PRAX

-$1.59M-342%

Neurocrine BiosciencesNBIX

$400K-95.6%

BridgeBio PharmaBBIO

-$8K—

Other financials

Income statement

See full

Revenue--100%

Operating income-$112.3M-54.4%

Net income-$102.3M-57.3%

EPS (diluted)-$1.17-41.0%

Balance sheet

See full

Cash & equivalents$545.9M+368%

Total debt$7.5M-13.6%

Total equity$1.3B+90.0%

Total assets$1.4B+86.6%

Cash flow

See full

Operating cash flow-$88.9M-44.2%

CapEx$133.0K+209%

Free cash flow-$89.0M-44.3%

Valuation

See full

Market cap$5.11B+116%

Profitability

See full

Operating margin-4,974.3%—

Net margin-4,612.1%—

FCF margin-3,732.2%—

Returns & leverage

See full

Return on equity-37.5%+8.7pp

Debt / equity0×0.0×

Current ratio27.8×+10.1×

Where this comes from

Reported directly by Xenon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xenon Pharmaceuticals's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xenon Pharmaceuticals's AOCI?: Xenon Pharmaceuticals (XENE) reported AOCI of -$1.21M in Q1 2026.
How has Xenon Pharmaceuticals's AOCI changed year-over-year?: Xenon Pharmaceuticals's AOCI decreased by 44.9% year-over-year, from -$836K to -$1.21M.
What is the long-term trend for Xenon Pharmaceuticals's AOCI?: Over 5 years (2020 to 2025), Xenon Pharmaceuticals's AOCI has grown at a -19.5% compound annual growth rate (CAGR), from -$990K to $335K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.